Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hello Tomorrow is a global organization and innovation hub dedicated to accelerating deep tech startups, with a primary focus on biotechnology, healthcare, and other science-driven sectors. Founded in 2011 and headquartered in Paris, the company operates as a critical bridge between early-stage researchers, investors, and large industrial corporations. It is best known for organizing the Hello Tomorrow Global Challenge, one of the world's largest startup competitions for science-based ventures, and the annual Global Summit. Beyond events, Hello Tomorrow provides strategic consultancy, market intelligence, and acceleration programs to help transition breakthrough laboratory innovations into commercial applications. While not a drug developer itself, the organization is a central pillar of the international life sciences ecosystem, fostering the growth of companies working on advanced modalities such as gene therapy and synthetic biology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hello Tomorrow.